Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements.
Identifieur interne : 006065 ( PubMed/Curation ); précédent : 006064; suivant : 006066Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements.
Auteurs : G. Belcaro ; A. Rulo ; C. CandianiSource :
- VASA. Zeitschrift fur Gefasskrankheiten [ 0301-1526 ] ; 1989.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Anticoagulants (usage thérapeutique), Attribution aléatoire, Essais cliniques comme sujet, Femelle, Humains, Insuffisance veineuse (sang), Insuffisance veineuse (traitement médicamenteux), Jambe (), Lasers, Lymphoedème (traitement médicamenteux), Mesure transcutanée des gaz du sang, Microcirculation (), Mâle, O-(bêta-Hydroxyéthyl)rutosides (analogues et dérivés), O-(bêta-Hydroxyéthyl)rutosides (usage thérapeutique), Pression veineuse (), Rutoside (analogues et dérivés), Syndrome post-phlébitique (sang), Syndrome post-phlébitique (traitement médicamenteux).
- MESH :
- analogues et dérivés : O-(bêta-Hydroxyéthyl)rutosides, Rutoside.
- sang : Insuffisance veineuse, Syndrome post-phlébitique.
- traitement médicamenteux : Insuffisance veineuse, Lymphoedème, Syndrome post-phlébitique.
- usage thérapeutique : Anticoagulants, O-(bêta-Hydroxyéthyl)rutosides.
- Adulte d'âge moyen, Attribution aléatoire, Essais cliniques comme sujet, Femelle, Humains, Jambe, Lasers, Mesure transcutanée des gaz du sang, Microcirculation, Mâle, Pression veineuse.
English descriptors
- KwdEn :
- Anticoagulants (therapeutic use), Blood Gas Monitoring, Transcutaneous, Clinical Trials as Topic, Female, Humans, Hydroxyethylrutoside (analogs & derivatives), Hydroxyethylrutoside (therapeutic use), Lasers, Leg (blood supply), Lymphedema (drug therapy), Male, Microcirculation (drug effects), Middle Aged, Postphlebitic Syndrome (blood), Postphlebitic Syndrome (drug therapy), Random Allocation, Rutin (analogs & derivatives), Venous Insufficiency (blood), Venous Insufficiency (drug therapy), Venous Pressure (drug effects).
- MESH :
- chemical , analogs & derivatives : Hydroxyethylrutoside, Rutin.
- chemical , therapeutic use : Anticoagulants, Hydroxyethylrutoside.
- blood : Postphlebitic Syndrome, Venous Insufficiency.
- blood supply : Leg.
- drug effects : Microcirculation, Venous Pressure.
- drug therapy : Lymphedema, Postphlebitic Syndrome, Venous Insufficiency.
- Blood Gas Monitoring, Transcutaneous, Clinical Trials as Topic, Female, Humans, Lasers, Male, Middle Aged, Random Allocation.
Abstract
The evaluation of the effects of venoactive drugs and particularly of Venoruton may be performed using microcirculatory parameters. Laserdoppler flowmetry may be used in association with PO2/PCO2 measurements. In this study we combined the microcirculatory evaluation with foot and leg volumetry to evaluate the effects of Venoruton in 15 patients with deep (popliteal vein) incompetence and venous hypertension, treated for 6 weeks. A control group of 20 patients was also evaluated. All these subjects were studied and selected according to ambulatory venous pressure measurements (AVP) and duplex scanning. Measurements were made at the internal perimalleolar region in constant temperature condition (23 degrees C). No variations of AVP or duplex scanning findings were observed after 6 weeks in both treated and untreated patients. Laserdoppler flowmetry showed a significant decrease of the resting flow (which was increased in all patients at the beginning of the study). An increased efficacy of the venoarteriolar response was also recorded together with an increased response of skin flow after increase of temperature in the perimalleolar region in patients treated with Venoruton. This was also associated with an increase of skin PO2 and with a decreased PCO2. In the control group no significant variations of these parameters were observed. Leg volume was also significantly decreased in the patients treated with Venoruton while no changes were observed in controls. In conclusion this study showed the efficacy of Venoruton in improving parameters altered in venous hypertension and the possibility of application of this microcirculatory model to study venoactive drugs used for treating venous hypertension.
PubMed: 2662674
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :006065
Links to Exploration step
pubmed:2662674Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements.</title><author><name sortKey="Belcaro, G" sort="Belcaro, G" uniqKey="Belcaro G" first="G" last="Belcaro">G. Belcaro</name></author><author><name sortKey="Rulo, A" sort="Rulo, A" uniqKey="Rulo A" first="A" last="Rulo">A. Rulo</name></author><author><name sortKey="Candiani, C" sort="Candiani, C" uniqKey="Candiani C" first="C" last="Candiani">C. Candiani</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1989">1989</date><idno type="RBID">pubmed:2662674</idno><idno type="pmid">2662674</idno><idno type="wicri:Area/PubMed/Corpus">006065</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">006065</idno><idno type="wicri:Area/PubMed/Curation">006065</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">006065</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements.</title><author><name sortKey="Belcaro, G" sort="Belcaro, G" uniqKey="Belcaro G" first="G" last="Belcaro">G. Belcaro</name></author><author><name sortKey="Rulo, A" sort="Rulo, A" uniqKey="Rulo A" first="A" last="Rulo">A. Rulo</name></author><author><name sortKey="Candiani, C" sort="Candiani, C" uniqKey="Candiani C" first="C" last="Candiani">C. Candiani</name></author></analytic><series><title level="j">VASA. Zeitschrift fur Gefasskrankheiten</title><idno type="ISSN">0301-1526</idno><imprint><date when="1989" type="published">1989</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anticoagulants (therapeutic use)</term><term>Blood Gas Monitoring, Transcutaneous</term><term>Clinical Trials as Topic</term><term>Female</term><term>Humans</term><term>Hydroxyethylrutoside (analogs & derivatives)</term><term>Hydroxyethylrutoside (therapeutic use)</term><term>Lasers</term><term>Leg (blood supply)</term><term>Lymphedema (drug therapy)</term><term>Male</term><term>Microcirculation (drug effects)</term><term>Middle Aged</term><term>Postphlebitic Syndrome (blood)</term><term>Postphlebitic Syndrome (drug therapy)</term><term>Random Allocation</term><term>Rutin (analogs & derivatives)</term><term>Venous Insufficiency (blood)</term><term>Venous Insufficiency (drug therapy)</term><term>Venous Pressure (drug effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Anticoagulants (usage thérapeutique)</term><term>Attribution aléatoire</term><term>Essais cliniques comme sujet</term><term>Femelle</term><term>Humains</term><term>Insuffisance veineuse (sang)</term><term>Insuffisance veineuse (traitement médicamenteux)</term><term>Jambe ()</term><term>Lasers</term><term>Lymphoedème (traitement médicamenteux)</term><term>Mesure transcutanée des gaz du sang</term><term>Microcirculation ()</term><term>Mâle</term><term>O-(bêta-Hydroxyéthyl)rutosides (analogues et dérivés)</term><term>O-(bêta-Hydroxyéthyl)rutosides (usage thérapeutique)</term><term>Pression veineuse ()</term><term>Rutoside (analogues et dérivés)</term><term>Syndrome post-phlébitique (sang)</term><term>Syndrome post-phlébitique (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Hydroxyethylrutoside</term><term>Rutin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticoagulants</term><term>Hydroxyethylrutoside</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>O-(bêta-Hydroxyéthyl)rutosides</term><term>Rutoside</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Postphlebitic Syndrome</term><term>Venous Insufficiency</term></keywords><keywords scheme="MESH" qualifier="blood supply" xml:lang="en"><term>Leg</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Microcirculation</term><term>Venous Pressure</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lymphedema</term><term>Postphlebitic Syndrome</term><term>Venous Insufficiency</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Insuffisance veineuse</term><term>Syndrome post-phlébitique</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Insuffisance veineuse</term><term>Lymphoedème</term><term>Syndrome post-phlébitique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticoagulants</term><term>O-(bêta-Hydroxyéthyl)rutosides</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Blood Gas Monitoring, Transcutaneous</term><term>Clinical Trials as Topic</term><term>Female</term><term>Humans</term><term>Lasers</term><term>Male</term><term>Middle Aged</term><term>Random Allocation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Attribution aléatoire</term><term>Essais cliniques comme sujet</term><term>Femelle</term><term>Humains</term><term>Jambe</term><term>Lasers</term><term>Mesure transcutanée des gaz du sang</term><term>Microcirculation</term><term>Mâle</term><term>Pression veineuse</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The evaluation of the effects of venoactive drugs and particularly of Venoruton may be performed using microcirculatory parameters. Laserdoppler flowmetry may be used in association with PO2/PCO2 measurements. In this study we combined the microcirculatory evaluation with foot and leg volumetry to evaluate the effects of Venoruton in 15 patients with deep (popliteal vein) incompetence and venous hypertension, treated for 6 weeks. A control group of 20 patients was also evaluated. All these subjects were studied and selected according to ambulatory venous pressure measurements (AVP) and duplex scanning. Measurements were made at the internal perimalleolar region in constant temperature condition (23 degrees C). No variations of AVP or duplex scanning findings were observed after 6 weeks in both treated and untreated patients. Laserdoppler flowmetry showed a significant decrease of the resting flow (which was increased in all patients at the beginning of the study). An increased efficacy of the venoarteriolar response was also recorded together with an increased response of skin flow after increase of temperature in the perimalleolar region in patients treated with Venoruton. This was also associated with an increase of skin PO2 and with a decreased PCO2. In the control group no significant variations of these parameters were observed. Leg volume was also significantly decreased in the patients treated with Venoruton while no changes were observed in controls. In conclusion this study showed the efficacy of Venoruton in improving parameters altered in venous hypertension and the possibility of application of this microcirculatory model to study venoactive drugs used for treating venous hypertension.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">2662674</PMID><DateCreated><Year>1989</Year><Month>08</Month><Day>10</Day></DateCreated><DateCompleted><Year>1989</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0301-1526</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>2</Issue><PubDate><Year>1989</Year></PubDate></JournalIssue><Title>VASA. Zeitschrift fur Gefasskrankheiten</Title><ISOAbbreviation>VASA</ISOAbbreviation></Journal><ArticleTitle>Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements.</ArticleTitle><Pagination><MedlinePgn>146-51</MedlinePgn></Pagination><Abstract><AbstractText>The evaluation of the effects of venoactive drugs and particularly of Venoruton may be performed using microcirculatory parameters. Laserdoppler flowmetry may be used in association with PO2/PCO2 measurements. In this study we combined the microcirculatory evaluation with foot and leg volumetry to evaluate the effects of Venoruton in 15 patients with deep (popliteal vein) incompetence and venous hypertension, treated for 6 weeks. A control group of 20 patients was also evaluated. All these subjects were studied and selected according to ambulatory venous pressure measurements (AVP) and duplex scanning. Measurements were made at the internal perimalleolar region in constant temperature condition (23 degrees C). No variations of AVP or duplex scanning findings were observed after 6 weeks in both treated and untreated patients. Laserdoppler flowmetry showed a significant decrease of the resting flow (which was increased in all patients at the beginning of the study). An increased efficacy of the venoarteriolar response was also recorded together with an increased response of skin flow after increase of temperature in the perimalleolar region in patients treated with Venoruton. This was also associated with an increase of skin PO2 and with a decreased PCO2. In the control group no significant variations of these parameters were observed. Leg volume was also significantly decreased in the patients treated with Venoruton while no changes were observed in controls. In conclusion this study showed the efficacy of Venoruton in improving parameters altered in venous hypertension and the possibility of application of this microcirculatory model to study venoactive drugs used for treating venous hypertension.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Belcaro</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Rulo</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Candiani</LastName><ForeName>C</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D018848">Controlled Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vasa</MedlineTA><NlmUniqueID>0317051</NlmUniqueID><ISSNLinking>0301-1526</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006896">Hydroxyethylrutoside</NameOfSubstance></Chemical><Chemical><RegistryNumber>5G06TVY3R7</RegistryNumber><NameOfSubstance UI="D012431">Rutin</NameOfSubstance></Chemical><Chemical><RegistryNumber>7Y4N11PXO8</RegistryNumber><NameOfSubstance UI="C005865">troxerutin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001785" MajorTopicYN="Y">Blood Gas Monitoring, Transcutaneous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006896" MajorTopicYN="N">Hydroxyethylrutoside</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007834" MajorTopicYN="Y">Lasers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007866" MajorTopicYN="N">Leg</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008833" MajorTopicYN="N">Microcirculation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011186" MajorTopicYN="N">Postphlebitic Syndrome</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012431" MajorTopicYN="N">Rutin</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014689" MajorTopicYN="N">Venous Insufficiency</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014690" MajorTopicYN="N">Venous Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1989</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1989</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1989</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">2662674</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006065 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 006065 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:2662674
|texte= Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:2662674" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |